BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30156153)

  • 21. Catheter Ablation for Atrial Fibrillation in Patients with Chronic Kidney Disease and on Dialysis: A Meta-Analysis and Review.
    Chung I; Khan Y; Warrens H; Seshasai RK; Sohal M; Banerjee D
    Cardiorenal Med; 2022; 12(4):155-172. PubMed ID: 35820393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: A propensity-matched study of 24,244 patients.
    Noseworthy PA; Kapa S; Deshmukh AJ; Madhavan M; Van Houten H; Haas LR; Mulpuru SK; McLeod CJ; Asirvatham SJ; Friedman PA; Shah ND; Packer DL
    Heart Rhythm; 2015 Jun; 12(6):1154-61. PubMed ID: 25708883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Sinus Node Recovery Time after Long-Standing Atrial Fibrillation Termination on the Long-Term Outcome of Catheter Ablation.
    Yamaguchi N; Okumura Y; Watanabe I; Nagashima K; Takahashi K; Iso K; Watanabe R; Arai M; Mano H; Kogawa R; Kurokawa S; Ohkubo K; Nakai T; Hirayama A; Sonoda K; Tosaka T
    Int Heart J; 2018 May; 59(3):497-502. PubMed ID: 29743409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study.
    Hellman T; Kiviniemi T; Vasankari T; Nuotio I; Biancari F; Bah A; Hartikainen J; Mäkäräinen M; Airaksinen KE
    BMC Cardiovasc Disord; 2017 Jan; 17(1):33. PubMed ID: 28100174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in renal and endothelial function after catheter ablation in patients with persistent atrial fibrillation.
    Okawa K; Miyoshi T; Sogo M; Hara S; Sudo Y; Ugawa S; Takahashi M; Doi M; Morita H; Ito H
    J Cardiol; 2020 Dec; 76(6):610-617. PubMed ID: 32682629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of recurrence after catheter ablation and electrical cardioversion of atrial fibrillation: an umbrella review of meta-analyses.
    Charitakis E; Dragioti E; Stratinaki M; Korela D; Tzeis S; Almroth H; Liuba I; Jönsson AH; Charalambous G; Karlsson LO; Tsartsalis D
    Europace; 2023 Feb; 25(1):40-48. PubMed ID: 36037026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epicardial fat thickness: A new predictor of successful electrical cardioversion and atrial fibrillation recurrence.
    Dereli S; Bayramoğlu A; Yontar OC; Cerşit S; Gürsoy MO
    Echocardiography; 2018 Dec; 35(12):1926-1931. PubMed ID: 30387182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catheter ablation for paroxysmal and persistent atrial fibrillation.
    Chen HS; Wen JM; Wu SN; Liu JP
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007101. PubMed ID: 22513945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in patients requiring cardioversion following catheter ablation of atrial fibrillation.
    Chilukuri K; Dukes J; Dalal D; Marine JE; Henrikson CA; Scherr D; Sinha S; Berger R; Cheng A; Nazarian S; Spragg D; Calkins H
    J Cardiovasc Electrophysiol; 2010 Jan; 21(1):27-32. PubMed ID: 19793148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left atrial pressure pattern without a-wave in sinus rhythm after cardioversion affects the outcomes after catheter ablation for atrial fibrillation.
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    Heart Vessels; 2018 Nov; 33(11):1365-1372. PubMed ID: 29691642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in renal function after catheter ablation in patients with persistent atrial fibrillation].
    Kong Y; Ma CS; Tang RB; Lin J; Cai JF
    Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):566-570. PubMed ID: 30060327
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion.
    Kang JH; Lee DI; Kim S; Kim MN; Park YM; Ban JE; Choi JI; Lim HE; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1165-70. PubMed ID: 22882453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of chronic kidney disease on atrial fibrillation recurrence following radiofrequency and cryoballoon ablation: A meta-analysis.
    Lee WC; Wu PJ; Fang CY; Chen HC; Chen MC
    Int J Clin Pract; 2021 Oct; 75(10):e14173. PubMed ID: 33756030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal dysfunction and atrial fibrillation recurrence following cardioversion.
    Schmidt M; Daccarett M; Rittger H; Marschang H; Holzmann S; Jung P; Bojanic D; Ketteler M; Brachmann J; Rieber J
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1092-8. PubMed ID: 21489032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.
    García-Fernández A; Marín F; Roldán V; Galcerá-Jornet E; Martínez-Martínez JG; Valdés M; Sogorb F; Lip GY
    Int J Cardiol; 2016 Aug; 217():42-8. PubMed ID: 27179207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome.
    Baman TS; Gupta SK; Billakanty SR; Ilg KJ; Good E; Crawford T; Jongnarangsin K; Ebinger M; Pelosi F; Bogun F; Chugh A; Morady F; Oral H
    J Cardiovasc Electrophysiol; 2009 Dec; 20(12):1321-5. PubMed ID: 19602031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of the influence of chronic kidney disease on the risk of thromboembolism among patients with nonvalvular atrial fibrillation.
    Providência R; Marijon E; Boveda S; Barra S; Narayanan K; Le Heuzey JY; Gersh BJ; Gonçalves L
    Am J Cardiol; 2014 Aug; 114(4):646-53. PubMed ID: 25001152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.